ZA200207221B
|
|
Alprazolam inclusion complexes and pharmaceutical compositions thereof.
|
WO0172338A1
|
|
Alprazolam inclusion complexes and pharmaceutical compositions thereof
|
WO0130391A2
|
|
Pharmaceutical composition containing midazolam
|
ZA200001002B
|
|
Inclusion complex.
|
AU4717997A
|
|
Inclusion complexes of beta-2-andrenergics for oral mucosal delivery
|
ZA9709447B
|
|
Pharmaceutical composition.
|
ZA9706179B
|
|
Pharmaceutical composition for transdermal or transmucosal delivery.
|
IL127956D0
|
|
Inclusion complex containing indole selective serotonin agonist
|
ZA9706178B
|
|
Inclusion complex.
|
CN1225018A
|
|
Inclusion complex containing indole selective serotonin agonist
|
ZA9704576B
|
|
Pharmaceutical composition.
|
AU1885797A
|
|
Peak-flow monitor
|
ZA9701453B
|
|
Peak-flow monitor.
|
ZA9610630B
|
|
Process
|
AU1182897A
|
|
A process for the optical resolution of 3-(p-chlorophenyl)-glutaramide
|
AU7637296A
|
|
Complex of naproxen and beta-cyclodextrin
|
ZA9609476B
|
|
Complex
|
ZA9604193B
|
|
Pharmaceutical composition
|
US5622716A
|
|
Process for preparing a retard product containing diltiazem for a single daily administration
|
ZA9602214B
|
|
Pharmaceutical composition
|